SCHEMBL4885465

SCHEMBL4885465

CCCCOC(=O)N(CC)c1nc([AsH2])c(I)c2[nH]cnc12

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
XDH P47989 3/20 0.33
CDK1 P06493 2/20 0.33
CCNB1 P14635 2/20 0.33
CCNA2 P20248 2/20 0.33
CDK2 P24941 2/20 0.33
CCNA1 P78396 2/20 0.33
PIN1 Q13526 1/20 0.33
CSNK2A2 P19784 1/20 0.31
CSNK2A1 P68400 1/20 0.31
ESR1 P03372 1/20 0.30
HSP90AA1 P07900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6143321 0.63 NAAA (0.46) LMNANPC1ALDH1A1RAB9AESR1
SCHEMBL13038947 0.63 LMNA (0.71) LMNAKDM4ENPC1ALDH1A1HPGD
SCHEMBL27809975 0.62 CDK1 (0.44) LMNAKDM4ENPC1ALDH1A1HPGD
SCHEMBL9540186 0.61 LMNA (0.46) LMNAKDM4ENPC1ALDH1A1HPGD
SCHEMBL27809973 0.60 CDK1 (0.42) LMNAKDM4ENPC1ALDH1A1HPGD
SCHEMBL15020359 0.60 SIGMAR1 (0.37) LMNAKDM4ENPC1ALDH1A1HPGD
SCHEMBL5737663 0.59 TSHR (0.55) LMNAKDM4ENPC1ALDH1A1HPGD
SCHEMBL9543012 0.59 LMNA (0.43) LMNAKDM4ENPC1ALDH1A1HPGD
SCHEMBL9540433 0.59 LMNA (0.43) LMNAKDM4ENPC1ALDH1A1HPGD
SCHEMBL21382113 0.58 ALDH1A1 (0.47) LMNAKDM4ENPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1888584-A1 1, 6 -DIHYDRO- 1,3, 5, 6-TETRAAZA-AS-INDACENE BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AS INHIBITORS OF IKK ENZYME ACTIVITY Brystol-Myers Squibb Company (US) 2008-02-20 EP disclosed
WO-2006122137-A1 1, 6 -DIHYDRO- 1,3, 5, 6-TETRAAZA-AS-INDACENE BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AS INHIBITORS OF IKK ENZYME ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2006-11-16 WO disclosed